One CBD brand has seen sales soar since the first UK lockdown last March, as mental health issues are amplified by the pandemic.
Since COVID-19 hit the UK in March last year, many have found that CBD has offered much-needed stress relief and helped curb the mental health pressures that have been amplified by the pandemic.
The third most popular reason for purchase was pain relief (67 percent), followed by improving focus (50 percent). Forty five percent of customers claimed ‘recovery’ was their reason for purchasing CBD.
Founder and CEO of Purity Hemp Company Michael Walker, who is also a trustee of Mental Health Associates, said: “For some, lockdown was a time to rest and reset but for many others, it was a time of frenetic stress, which is set to continue as restrictions start to relax and we adapt back into our previous lifestyles.”
The company says that its CBD edibles have been the most popular of its products, with sales of its 300mg edible gummy domes increasing by 600 percent. Meanwhile, its CBD tea saw a 400 percent uplift in sales and the brand’s 10 percent CBD oil saw a boost of 250 percent.
Purity Hemp Company’s range of topicals also saw a boost in sales with an increase of 500 percent. It puts this, in part, down to the impact that working from home has had on the nation’s physical health.
“We have close relationships with our loyal customers and we know what health problems they are targeting with their CBD use. We’re happy to have been able to help them cope with the multiple stresses of the last year and are dedicated to continuing to help them on their journeys,” Walker added.
“Being a trustee of the Mental Health Associates allows me to give back to an industry that has provided so much to me over the last 20 years. It’s a cause close to my heart and my experience in the CBD industry helps give me a solid understanding of the pressures that some individuals face. It’s great to know we are able to offer relief to them through our products at what continues to be a difficult time for many.”
Pandemic-induced stress and other mental health issues, which have been widely acknowledged by health professionals, are likely to continue as measures begin to relax.
This is being referred to as ‘post lockdown anxiety’, a phrase coined by mental health charity Anxiety UK.
A recent survey from the charity presented a ‘mixed picture’ of views regarding the return to the so-called new normal.
The survey revealed that although 37 percent were looking forward to a return to normal life, 36 percent were ‘happy’ to stay at home and 27 percent had no strong feeling either way.
- Malta gives green light to three new cannabis clubs
- European Commission must address ‘inequality’ in access to medicinal cannabis across EU
- 1 in 8 older US adults now use cannabis products, finds study
- 3 main contributors to the entourage effect for cannabis consumers to consider
- Medical cannabis doesn’t impair cognitive function – study
- Ukraine’s medical cannabis legalisation delayed by opponents
- News4 months ago
NHS approves major clinical trial on cannabis medicines and chronic pain
- News6 months ago
UK patient secures first NHS reimbursement for cannabis flowers
- Advocacy6 months ago
Inside a UK cannabis club: changing lives, tackling stigma, building community
- News4 months ago
UK research finds GP support for cannabis as an alternative to opioids for chronic pain
- Industry4 months ago
‘Landmark’ ruling gives hope for UK CBD flower businesses
- News4 months ago
Malta: Advocates emphasise positive effects of cannabis reform amid ‘normalisation’ concerns
- Science4 months ago
Five new cannabis studies – ALS, epilepsy, Parkinson’s, chronic pain and blood pressure
- Science6 months ago
New research suggests alcohol, not cannabis, is the real ‘gateway’ drug